An Updated Overview of Low Back Pain Management
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Jae-Young | - |
dc.contributor.author | Song, Kwang-Sup | - |
dc.contributor.author | Cho, Jae Hwan | - |
dc.contributor.author | Lee, Jae Hyup | - |
dc.contributor.author | Kim, Nack Hwan | - |
dc.date.accessioned | 2022-02-07T04:42:30Z | - |
dc.date.available | 2022-02-07T04:42:30Z | - |
dc.date.issued | 2022-12 | - |
dc.identifier.issn | 1976-1902 | - |
dc.identifier.issn | 1976-7846 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/54892 | - |
dc.description.abstract | We aimed to determine the recommendation level for the treatment of acute and chronic low back pain (LBP). A systematic review (SR) of the literature was performed and all English-language articles that discuss acute and chronic LBP, including MEDLINE and the Cochrane Database of Systematic Reviews, were searched. Of the 873 searched literature reports, 259 articles, including 131 clinical trials, 115 SRs, nine meta-analyses, and four clinical guidelines were analyzed. In these articles, high-quality randomized controlled trials, SRs, and used well-written clinical guidelines were reviewed. The results indicated multiple acute and chronic LBP treatment methods in the literature, and these reports when reviewed included general behavior, pharmacological therapy, psychological therapy, specific exercise, active rehabilitation and educational interventions, manual therapy, physical modalities, and invasive procedures. The Trial conclusions and SRs were classified into four categories of A, B, C, and D. If there were not enough high-quality articles, it was designated as "I" (insufficient). This review and summary of guidelines may be beneficial for physicians to better understand and make recommendations in primary care. | - |
dc.format.extent | 15 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | KOREAN SOC SPINE SURGERY | - |
dc.title | An Updated Overview of Low Back Pain Management | - |
dc.title.alternative | An Updated Overview of Low Back Pain Management | - |
dc.type | Article | - |
dc.identifier.doi | 10.31616/asj.2021.0371 | - |
dc.identifier.bibliographicCitation | ASIAN SPINE JOURNAL, v.16, no.6, pp 968 - 982 | - |
dc.identifier.kciid | ART002912218 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000742880800001 | - |
dc.identifier.scopusid | 2-s2.0-85125903888 | - |
dc.citation.endPage | 982 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 968 | - |
dc.citation.title | ASIAN SPINE JOURNAL | - |
dc.citation.volume | 16 | - |
dc.type.docType | Review | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Low back pain | - |
dc.subject.keywordAuthor | Treatment guidelines | - |
dc.subject.keywordAuthor | Recommendations | - |
dc.subject.keywordPlus | BUPRENORPHINE TRANSDERMAL SYSTEM | - |
dc.subject.keywordPlus | RANDOMIZED CONTROLLED-TRIAL | - |
dc.subject.keywordPlus | PLACEBO-CONTROLLED TRIAL | - |
dc.subject.keywordPlus | OXYMORPHONE EXTENDED-RELEASE | - |
dc.subject.keywordPlus | SPINAL MANIPULATIVE THERAPY | - |
dc.subject.keywordPlus | QUALITY-OF-LIFE | - |
dc.subject.keywordPlus | INTERLAMINAR EPIDURAL INJECTIONS | - |
dc.subject.keywordPlus | OPIOID-EXPERIENCED PATIENTS | - |
dc.subject.keywordPlus | FACET JOINT INJECTION | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.relation.journalResearchArea | Orthopedics | - |
dc.relation.journalWebOfScienceCategory | Orthopedics | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.